73 related articles for article (PubMed ID: 7027565)
1. [Renal changes in early diabetes. The disease and a disease model].
Seyer-Hansen K
Ugeskr Laeger; 1981 Mar; 143(14):874-8. PubMed ID: 7027565
[No Abstract] [Full Text] [Related]
2. Early functional and morphological changes in diabetic nephropathy.
Viberti GC
Clin Nephrol; 1979 Aug; 12(2):47-53. PubMed ID: 527270
[No Abstract] [Full Text] [Related]
3. Abnormal renal structural alterations during the development of diabetes mellitus in Otsuka Long-Evans Tokushima Fatty rats.
Koike T; Tomoda F; Kinuno H; Inoue H; Takata M
Acta Physiol Scand; 2005 May; 184(1):73-81. PubMed ID: 15847646
[TBL] [Abstract][Full Text] [Related]
4. Renal structure and function in type 2 diabetic patients with or without diabetic nephropathy.
Christensen PK
Dan Med Bull; 2004 Feb; 51(1):82-103. PubMed ID: 16009073
[No Abstract] [Full Text] [Related]
5. Inhibition of vascular endothelial growth factor (VEGF) does not affect early renal changes in a rat model of lean type 2 diabetes.
Schrijvers BF; De Vriese AS; Tilton RG; Van de Voorde J; Denner L; Lameire NH; Flyvbjerg A
Horm Metab Res; 2005 Jan; 37(1):21-5. PubMed ID: 15702434
[TBL] [Abstract][Full Text] [Related]
6. Is glomerular filtration rate in children after 5 years of type 1 diabetes associated with development of albuminuria?
Araki S
Nat Clin Pract Nephrol; 2006 May; 2(5):242-3. PubMed ID: 16932432
[No Abstract] [Full Text] [Related]
7. Pravastatin modulates early diabetic nephropathy in an experimental model of diabetic renal disease.
Casey RG; Joyce M; Roche-Nagle G; Chen G; Bouchier-Hayes D
J Surg Res; 2005 Feb; 123(2):176-81. PubMed ID: 15680375
[TBL] [Abstract][Full Text] [Related]
8. Effects of p38 mitogen-activated protein kinase inhibition on blood pressure, renal hemodynamics, and renal vascular reactivity in normal and diabetic rats.
Komers R; Schutzer W; Xue H; Oyama TT; Lindsley JN; Anderson S
Transl Res; 2007 Dec; 150(6):343-9. PubMed ID: 18022596
[TBL] [Abstract][Full Text] [Related]
9. Renal microvascular changes in streptozotocin-induced, long-termed diabetic rat.
Sricharoenvej S; Tongpob Y; Lanlua P; Piyawinijwong S; Roongruangchai J; Phoungpetchara I
J Med Assoc Thai; 2007 Dec; 90(12):2677-82. PubMed ID: 18386720
[TBL] [Abstract][Full Text] [Related]
10. [Diabetic nephropathy: physiopathology and clinical course].
Macía Heras M; Macía Jerez M; Coronel F
Nefrologia; 2001; 21 Suppl 3():24-31. PubMed ID: 11642203
[No Abstract] [Full Text] [Related]
11. Effect of calcium channel blockade on adrenergically induced renal vasoconstriction in rat models of renal impairment.
Khan AH; Sattar MA; Abdullah NA; Johns EJ
Clin Exp Pharmacol Physiol; 2009 May; 36(5-6):501-8. PubMed ID: 19673932
[TBL] [Abstract][Full Text] [Related]
12. Cardiovascular and renal characteristics, and responses to acute volume expansion of a rat model of diabetic pregnancy.
Tang D; Yu T; Khraibi AA
Life Sci; 2004 Apr; 74(23):2909-18. PubMed ID: 15050428
[TBL] [Abstract][Full Text] [Related]
13. Long-term renal changes in the Goto-Kakizaki rat, a model of lean type 2 diabetes.
Schrijvers BF; De Vriese AS; Van de Voorde J; Rasch R; Lameire NH; Flyvbjerg A
Nephrol Dial Transplant; 2004 May; 19(5):1092-7. PubMed ID: 14993490
[TBL] [Abstract][Full Text] [Related]
14. Can rodent models of diabetic kidney disease clarify the significance of early hyperfiltration?: recognizing clinical and experimental uncertainties.
Levine DZ
Clin Sci (Lond); 2008 Jan; 114(2):109-18. PubMed ID: 18062776
[TBL] [Abstract][Full Text] [Related]
15. Increased renal collagen cross-linking and lipid accumulation in nephropathy of Zucker diabetic fatty rats.
Li Y; Qi Y; Kim MS; Xu KZ; Huang TH; Rong X; Murray M; Yamahara J
Diabetes Metab Res Rev; 2008 Sep; 24(6):498-506. PubMed ID: 18613221
[TBL] [Abstract][Full Text] [Related]
16. Diabetic nephropathy is associated with oxidative stress and decreased renal nitric oxide production.
Prabhakar S; Starnes J; Shi S; Lonis B; Tran R
J Am Soc Nephrol; 2007 Nov; 18(11):2945-52. PubMed ID: 17928507
[TBL] [Abstract][Full Text] [Related]
17. A model for diabetic nephropathy: advantages of the inducible cAMP early repressor transgenic mouse over the streptozotocin-induced diabetic mouse.
Inada A; Kanamori H; Arai H; Akashi T; Araki M; Weir GC; Fukatsu A
J Cell Physiol; 2008 May; 215(2):383-91. PubMed ID: 18270980
[TBL] [Abstract][Full Text] [Related]
18. [Kidney hypertrophy-hyperfunction correlation in rapid onset infantile-juvenile diabetes mellitus].
Garciá Puig J; Mateos Antón F; Grande C; Pallardo LF; Gaspar G; Lesmes A; Cerdán A; Arnalich F; Anciones B; Gil Aguado A; Vázquez JJ; Montero A
Rev Clin Esp; 1980 Dec; 159(6):389-92. PubMed ID: 7221105
[No Abstract] [Full Text] [Related]
19. [The kidney as a target organ in diabetic patients with arterial hypertension].
Viberti G
Drugs; 2003; 63 Spec No 1():31-7. PubMed ID: 12708880
[TBL] [Abstract][Full Text] [Related]
20. Diabetic nephropathy in an aerobically trained rat model of diabetes.
Albright AL; Mahan JD; Ward KM; Sherman WM; Roehrig KL; Kirby TE
Med Sci Sports Exerc; 1995 Sep; 27(9):1270-7. PubMed ID: 8531625
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
